Lisa von Moltke, M.D.

Lisa von Moltke, M.D.

Head of Research and Development and Chief Medical OfficeratZenas BioPharma· In the 2025 proxy

Pay in FY2025Zenas BioPharma stock +343.3% the same year

Lisa von Moltke, M.D. was paid $3.5M in FY2025 (Dec). Zenas BioPharma stock rose 343.3% that year.

Pay$100 in the stock at the end of FY24 → $443
Pay is from the Summary Compensation Table of each Zenas BioPharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zenas BioPharmaPublic company · 1 yr
    • Head of Research and Development and Chief Medical Officer2025 – Present · 1 yrStock in role +195%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?